Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone mini-pulse therapy in ICU COVID-19 patients
IRCT20170716035126N4Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone in coronavirus disease 2019 (COVID-19), sponsored by Ardabil University of Medical Sciences. Started Jul 2020; status: completed.
02
Drugs
methylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20170716035126N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170716035126N4.